FDA WON’T RE-SCHEDULE MARIJUANA BUT WILL ALLOW RESEARCH

The FDA has decided that it will not re-schedule marijuana under the Federal Controlled Substance Act but will allow more research of marijuana.   After months of speculation of whether the FDA would reschedule marijuana from a Schedule I drug to a Schedule II, the FDA is electing to take this half-hearted measure. The Federal government’s … Continue reading FDA WON’T RE-SCHEDULE MARIJUANA BUT WILL ALLOW RESEARCH